BackPacific Biosciences of California Overview

Pacific Biosciences of California Other Current Assets

Latest other current assets for PACB: $9.8M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$9.84M
↓ 96.13% YoYΔ $-244.16M vs prior year quarter

Peer average / median

Loading

Pacific Biosciences of California Other Current Assets History

Loading

Pacific Biosciences of California vs. peers: Other Current Assets Comparison

Loading

Pacific Biosciences of California Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pacific Biosciences of California (PACB) FAQ

Pacific Biosciences of California (PACB) currently reports a other current assets of $9.8M as of September 2026. That compares with $250M in the prior-year period — down 96.1% year over year. Use the charts on this page to explore Pacific Biosciences of California's other current assets history and peer comparisons.

Pacific Biosciences of California's other current assets decreased from $250M to $9.8M — a 96.1% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pacific Biosciences of California reported $9.8M in other current assets as of September 2026. That compares with $250M in the prior-year period — down 96.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $9.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pacific Biosciences of California, and consider following PACB for alerts when major investors trade the stock.

Pacific Biosciences of California is classified in the Healthcare sector. On other current assets, it currently shows $9.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PACB with unrelated industries.